OCREVUS (ocrelizumab)

(Abst.) Recurrence of disease activity after ocrelizumab discontinuation in MS

Started by agate on 07 Oct, 2024 09:25
Last post by agate on 21 Jan, 2026 20:53

Views: 512, Replies: 1

(Abst.) Cardiogenic shock after ocrelizumab infusion in RRMS (MS Journal)

Started by agate on 01 Jan, 2026 21:55
Last post by agate on 02 Jan, 2026 21:29

Views: 13, Replies: 1

Severe late-onset neutropenia in a patient with MS treated with ocrelizumab

Started by agate on 27 Dec, 2025 21:15

Views: 6, Replies: 0

(ECTRIMS) Ocrelizumab may double serious infection risk in MS

Started by agate on 26 Oct, 2025 16:06

Views: 24, Replies: 0

(ACTRIMS abst.) MS patients treated with ocrelizumab, aged 70 and older...

Started by agate on 21 Mar, 2025 21:14
Last post by agate on 27 Apr, 2025 15:01

Views: 147, Replies: 1

Genentech updates Phase 3 Ocrevus high-dose study in people w/relapsing MS

Started by agate on 03 Apr, 2025 10:07

Views: 69, Replies: 0

Ocrevus biosimilar (Xacrel) shows equivalent efficacy as MS treatment

Started by agate on 02 Dec, 2024 20:43

Views: 110, Replies: 0

(Nature) Ocrelizumab biosimilar Xacrel compared to Ocrevus...

Started by agate on 22 Oct, 2024 21:11

Views: 328, Replies: 0

(Abst.) The wearing-off phenomenon of ocrelizumab in patients w/MS

Started by agate on 16 Feb, 2022 20:41
Last post by agate on 20 Oct, 2024 11:21

Views: 529, Replies: 1

Subcutaneous Ocrevus Zunovo has FDA approval

Started by agate on 14 Sep, 2024 16:58

Views: 402, Replies: 0

(Abst.) Ocrelizumab in people w/primary progressive MS...

Started by agate on 27 Jul, 2024 15:23

Views: 341, Replies: 0

Subcutaneous Ocrevus gets EU approval

Started by agate on 25 Jun, 2024 20:57
Last post by agate on 12 Jul, 2024 20:37

Views: 382, Replies: 1

Ocrelizumab-associated enteritis in patients w/MS: An emerging safety issue

Started by agate on 12 Jul, 2024 16:01

Views: 357, Replies: 0

(Abst.) Ocrelizumab in highly disabled progressive MS patients

Started by agate on 07 Jan, 2024 08:02

Views: 305, Replies: 0

(Abst.) Neutropenia complications from ocrelizumab and rituximab treatment

Started by agate on 04 Dec, 2023 11:04

Views: 297, Replies: 0

(JAMA) Rituximab vs ocrelizumab in RRMS

Started by agate on 12 Jun, 2023 10:09
Last post by agate on 27 Nov, 2023 16:18

Views: 3224, Replies: 4

(ECTRIMS) Ocrevus benefit confirmed in patients over 60 with MS

Started by agate on 13 Oct, 2023 20:41

Views: 398, Replies: 0

Phase III trial: Ocrevus twice yearly w/10-minute subcutaneous injection

Started by agate on 13 Jul, 2023 09:52
Last post by agate on 12 Oct, 2023 16:35

Views: 579, Replies: 3

OCREVUS (ocrelizumab)